NPM1 and acute myeloid leukemia: We performed IFNγ-ELISPOT assays to investigate the occurrence of NPM1-mutated-specific T cells in a total of 137 PB and 80 BM samples (Table 1), collected at different time points, from 31 adults, affected with NPM1-mutated AML (Figure 1).